File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Integration of chromosomal microarray into paediatric clinical care in Hong Kong

TitleIntegration of chromosomal microarray into paediatric clinical care in Hong Kong
Authors
KeywordsPediatrics
Issue Date2013
PublisherMedcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp
Citation
The 2013 Joint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, 8 September 2013. In Hong Kong Journal of Paediatrics (New series), 2013, v. 18 n. 4, p. 235 How to Cite?
AbstractChromosomal microarray (CMA) has emerged as a major tool to identify unbalanced chromosomal aberrations in children and is recommended as the first tiered investigation for intellectual disability, autism spectrum disorders and multiple congenital anomalies. While the clinical interpretation and genetic counseling remain as ongoing challenge, data about potential downstream benefits and harms of CMA is lacking, especially in paediatric population. Our objective is to evaluate the clinical impact of CMA on medical management in children. In 2011-2012, we performed high resolution CMA using the NimbleGen 135k oligonucleotide array on 240 children in a university-affiliated paediatric unit in Hong Kong. By retrospective chart review, descriptive and multivariate analyses are performed to understand the association between CMA results and change in the medical management. The detection rate of pathogenic/probably pathogenic chromosomal aberrations is 20% in our cohort. While detailed analysis is underway, it is clear that CMA detects chromosomal changes missed by karyotype in some patients, while in others it provides significant information in addition. Importantly these findings can be medically actionable and/or have major implications for family members. The insights we have learned from some of our patients have wider implications for the medical community e.g. the recommendation of cardiac assessment for patients with 17p13.3 duplication (Eur J Med Genet 2012; 55(12):758-62) and renal surveillance for patients with Xq22.3 deletion (Esophagus, in press), and have resulted in publications in peer-reviewed journals. One family with a neurodevelopmental phenotype and a probably pathogenic CMA finding has decided not to receive any further information as the parents realised that 'knowing more may not be better'. The potential of CMA findings to impact, positively and negatively, on patients is tremendous and warrants careful evaluation. Our findings will be instructive in anticipating the impact of whole genomic analyses on medical management and downstream utilisation of health services.
DescriptionOral Presentation (Doctor’s Session)
Open Access Journal : pp. 230-265 pf this journal issue is the Proceedings of Congress
Persistent Identifierhttp://hdl.handle.net/10722/190137
ISSN
2015 Impact Factor: 0.194
2015 SCImago Journal Rankings: 0.123

 

DC FieldValueLanguage
dc.contributor.authorTao, Ven_US
dc.contributor.authorShe, Wen_US
dc.contributor.authorChu, WYen_US
dc.contributor.authorTso, Wen_US
dc.contributor.authorChan, KYen_US
dc.contributor.authorLau, EYLen_US
dc.contributor.authorKan, Aen_US
dc.contributor.authorTang, MHen_US
dc.contributor.authorLau, YLen_US
dc.contributor.authorChung, BHYen_US
dc.date.accessioned2013-09-17T15:12:12Z-
dc.date.available2013-09-17T15:12:12Z-
dc.date.issued2013en_US
dc.identifier.citationThe 2013 Joint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, 8 September 2013. In Hong Kong Journal of Paediatrics (New series), 2013, v. 18 n. 4, p. 235en_US
dc.identifier.issn1013-9923-
dc.identifier.urihttp://hdl.handle.net/10722/190137-
dc.descriptionOral Presentation (Doctor’s Session)-
dc.descriptionOpen Access Journal : pp. 230-265 pf this journal issue is the Proceedings of Congress-
dc.description.abstractChromosomal microarray (CMA) has emerged as a major tool to identify unbalanced chromosomal aberrations in children and is recommended as the first tiered investigation for intellectual disability, autism spectrum disorders and multiple congenital anomalies. While the clinical interpretation and genetic counseling remain as ongoing challenge, data about potential downstream benefits and harms of CMA is lacking, especially in paediatric population. Our objective is to evaluate the clinical impact of CMA on medical management in children. In 2011-2012, we performed high resolution CMA using the NimbleGen 135k oligonucleotide array on 240 children in a university-affiliated paediatric unit in Hong Kong. By retrospective chart review, descriptive and multivariate analyses are performed to understand the association between CMA results and change in the medical management. The detection rate of pathogenic/probably pathogenic chromosomal aberrations is 20% in our cohort. While detailed analysis is underway, it is clear that CMA detects chromosomal changes missed by karyotype in some patients, while in others it provides significant information in addition. Importantly these findings can be medically actionable and/or have major implications for family members. The insights we have learned from some of our patients have wider implications for the medical community e.g. the recommendation of cardiac assessment for patients with 17p13.3 duplication (Eur J Med Genet 2012; 55(12):758-62) and renal surveillance for patients with Xq22.3 deletion (Esophagus, in press), and have resulted in publications in peer-reviewed journals. One family with a neurodevelopmental phenotype and a probably pathogenic CMA finding has decided not to receive any further information as the parents realised that 'knowing more may not be better'. The potential of CMA findings to impact, positively and negatively, on patients is tremendous and warrants careful evaluation. Our findings will be instructive in anticipating the impact of whole genomic analyses on medical management and downstream utilisation of health services.-
dc.languageengen_US
dc.publisherMedcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp-
dc.relation.ispartofHong Kong Journal of Paediatrics (New series)en_US
dc.subjectPediatrics-
dc.titleIntegration of chromosomal microarray into paediatric clinical care in Hong Kongen_US
dc.typeConference_Paperen_US
dc.identifier.emailTao, V: Taoqc@yahoo.comen_US
dc.identifier.emailChu, WY: chuwyy@hku.hken_US
dc.identifier.emailTso, W: wytso@hku.hken_US
dc.identifier.emailChan, KY: ykchanc@hku.hken_US
dc.identifier.emailLau, EYL: eyllau@hkucc.hku.hken_US
dc.identifier.emailKan, A: kansya@hku.hken_US
dc.identifier.emailTang, MH: mhytang@hkucc.hku.hken_US
dc.identifier.emailLau, YL: lauylung@hku.hken_US
dc.identifier.emailChung, BHY: bhychung@hku.hk-
dc.identifier.authorityTso, W=rp01517en_US
dc.identifier.authorityChan, KY=rp00453en_US
dc.identifier.authorityTang, MH=rp01701en_US
dc.identifier.authorityLau, YL=rp00361en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros225110en_US
dc.identifier.volume18-
dc.identifier.issue4-
dc.identifier.spage235en_US
dc.identifier.epage235en_US
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats